Guardant Health, Inc. logo

Guardant Health, Inc.

NASDAQ:GH

Overview | Financials
Company Name Guardant Health, Inc.
Symbol GH
Currency USD
Price 40.64
Market Cap 5,015,829,440
Dividend Yield 0%
52-week-range 15.81 - 50.89
Industry Diagnostics & Research
Sector Healthcare
CEO Dr. Helmy Eltoukhy Ph.D.
Website https://guardanthealth.com

An error occurred while fetching data.

About Guardant Health, Inc.

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset

Related Stocks

Amedisys, Inc. logo

Amedisys, Inc.

AMED

92.59 USD

Novavax, Inc. logo

Novavax, Inc.

NVAX

8.17 USD

Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

ARWR

15.07 USD

Surgery Partners, Inc. logo

Surgery Partners, Inc.

SGRY

23.61 USD

Cerevel Therapeutics Holdings, Inc. logo

Cerevel Therapeutics Holdings, Inc.

CERE

44.96 USD

LivaNova PLC logo

LivaNova PLC

LIVN

38.56 USD

Natera, Inc. logo

Natera, Inc.

NTRA

142.51 USD

Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

MMSI

97.66 USD

iRhythm Technologies, Inc. logo

iRhythm Technologies, Inc.

IRTC

97.77 USD

Financials

Numbers are in millions USD

Numbers are in millions USD